These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 26410440

  • 1. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
    Demirel B, İmamoglu E, Gursoy T, Demirel U, Topçuoglu S, Karatekin G, Ovali F.
    J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
    [Abstract] [Full Text] [Related]

  • 2. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O, Cambonie G, Barbotte E, Meyer P, Devine C, Milesi C, Pidoux O, Badr M, Picaud JC.
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [Abstract] [Full Text] [Related]

  • 3. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
    Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M, NeoVanc Consortium.
    Lancet Child Adolesc Health; 2022 Jan; 6(1):49-59. PubMed ID: 34843669
    [Abstract] [Full Text] [Related]

  • 4. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
    Duszynska W, Taccone FS, Hurkacz M, Wiela-Hojenska A, Kübler A.
    Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
    [Abstract] [Full Text] [Related]

  • 5. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
    van Maarseveen EM, Gipmans S, Vasbinder E, Petjak M, van Zanten AR.
    Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
    [Abstract] [Full Text] [Related]

  • 6. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
    Akers KS, Cota JM, Chung KK, Renz EM, Mende K, Murray CK.
    J Burn Care Res; 2012 Jun; 33(6):e254-62. PubMed ID: 22878490
    [Abstract] [Full Text] [Related]

  • 7. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A, Cranswick N, Metz D, Coghlan B, Daley AJ, Bryant PA, Curtis N.
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin for prophylaxis against sepsis in preterm neonates.
    Craft AP, Finer NN, Barrington KJ.
    Cochrane Database Syst Rev; 2000 Jun; 2000(2):CD001971. PubMed ID: 10796456
    [Abstract] [Full Text] [Related]

  • 9. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
    Beumier M, Roberts JA, Kabtouri H, Hites M, Cotton F, Wolff F, Lipman J, Jacobs F, Vincent JL, Taccone FS.
    J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
    [Abstract] [Full Text] [Related]

  • 10. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
    Covajes C, Scolletta S, Penaccini L, Ocampos-Martinez E, Abdelhadii A, Beumier M, Jacobs F, de Backer D, Vincent JL, Taccone FS.
    Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
    [Abstract] [Full Text] [Related]

  • 11. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, Müller M, Tschernko E.
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF, Kuhn TC, Brown DL.
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [Abstract] [Full Text] [Related]

  • 13. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
    Saugel B, Nowack MC, Hapfelmeier A, Umgelter A, Schultheiss C, Thies P, Phillip V, Eyer F, Schmid RM, Huber W.
    J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
    [Abstract] [Full Text] [Related]

  • 14. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
    van Maarseveen EM, Man WH, Touw DJ, Bouma AW, van Zanten AR.
    Ned Tijdschr Geneeskd; 2011 Feb; 155(42):A2667. PubMed ID: 22027450
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.
    Alan S, Yildiz D, Erdeve O, Cakir U, Kahvecioglu D, Okulu E, Ates C, Atasay B, Arsan S.
    Am J Perinatol; 2014 Dec; 31(12):1079-86. PubMed ID: 24584997
    [Abstract] [Full Text] [Related]

  • 16. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates.
    Ng SM, May JE, Emmerson AJ.
    Biol Neonate; 2005 Dec; 87(4):269-72. PubMed ID: 15695923
    [Abstract] [Full Text] [Related]

  • 17. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
    Tafelski S, Nachtigall I, Troeger U, Deja M, Krannich A, Günzel K, Spies C, ABx Study Group.
    J Infect Public Health; 2015 Dec; 8(4):355-63. PubMed ID: 25794497
    [Abstract] [Full Text] [Related]

  • 18. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Klepser ME, Patel KB, Nicolau DP, Quintiliani R, Nightingale CH.
    Pharmacotherapy; 1998 Dec; 18(5):1069-74. PubMed ID: 9758317
    [Abstract] [Full Text] [Related]

  • 19. How to use vancomycin optimally in neonates: remaining questions.
    Jacqz-Aigrain E, Leroux S, Zhao W, van den Anker JN, Sharland M.
    Expert Rev Clin Pharmacol; 2015 Dec; 8(5):635-48. PubMed ID: 26289222
    [Abstract] [Full Text] [Related]

  • 20. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A, Ling EW, Levine M.
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.